Tuesday, 7 May 2019


Bio printing Could be the New Solution to Organ Transplantation





3D technology is proving that the future looks quite different, with tissue engineering taking center stage, anticipating a possible future where organ transplants will not be needed to survive. One of the most well-known tissue engineering companies is San Diego-based Organovo. It has been actively developing a line of human tissues for use in medical research and drug discovery for years.
The company, one of the first big players in bioprinting, was founded in 2007 by Keith Murphy and Gabor Forgacs with a focus on developing in vivo liver tissues to treat a range of rare, life-threatening diseases, for which there are few current treatment options other than organ transplantation. Organovo’s ultimate goal in developing their liver therapeutic tissue is to delay or reduce the need for a transplant. The firm is also trying to harness their foundational ability to characterize specialized human cells and to 3D bioprint functional tissues to create novel in vitro toxicology and liver disease modeling platforms.
International Conference on Organ Donation and Transplantation Science

July 15-16, 2019 Sydney, Australia
Please visit: https://world.geneticconferences.com/

#transplantation  #organdonation  #donatelife #donar #kidney #lung #heart #transplant

No comments:

Post a comment